WO2001021147A1 - Diet and weight control gum and sucker - Google Patents
Diet and weight control gum and sucker Download PDFInfo
- Publication number
- WO2001021147A1 WO2001021147A1 PCT/US2000/025608 US0025608W WO0121147A1 WO 2001021147 A1 WO2001021147 A1 WO 2001021147A1 US 0025608 W US0025608 W US 0025608W WO 0121147 A1 WO0121147 A1 WO 0121147A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gum
- liquid
- substance
- diet
- component
- Prior art date
Links
- 235000005911 diet Nutrition 0.000 title claims abstract description 24
- 230000037213 diet Effects 0.000 title claims abstract description 23
- 238000004260 weight control Methods 0.000 title description 7
- 239000007937 lozenge Substances 0.000 claims abstract description 13
- 239000007788 liquid Substances 0.000 claims description 23
- 239000000126 substance Substances 0.000 claims description 22
- 235000009508 confectionery Nutrition 0.000 claims description 5
- 239000000203 mixture Substances 0.000 abstract description 13
- 235000011475 lollipops Nutrition 0.000 abstract description 11
- 238000000034 method Methods 0.000 description 20
- 239000000047 product Substances 0.000 description 12
- 208000008589 Obesity Diseases 0.000 description 10
- 235000020824 obesity Nutrition 0.000 description 10
- 239000003925 fat Substances 0.000 description 8
- 229920001661 Chitosan Polymers 0.000 description 5
- 238000007443 liposuction Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000002503 metabolic effect Effects 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 235000015218 chewing gum Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000019525 fullness Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 235000019627 satiety Nutrition 0.000 description 3
- 230000036186 satiety Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000019693 Lung disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 240000003444 Paullinia cupana Species 0.000 description 2
- 235000000556 Paullinia cupana Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 229940046374 chromium picolinate Drugs 0.000 description 2
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 231100000206 health hazard Toxicity 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 244000303965 Cyamopsis psoralioides Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 241000227647 Fucus vesiculosus Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000208253 Gymnema sylvestre Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 206010061291 Mineral deficiency Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010029897 Obsessive thoughts Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 208000005764 Peripheral Arterial Disease Diseases 0.000 description 1
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 1
- 208000018262 Peripheral vascular disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 240000001058 Sterculia urens Species 0.000 description 1
- 235000015125 Sterculia urens Nutrition 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047627 Vitamin deficiencies Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- -1 algmates Polymers 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000002830 appetite depressant Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000037221 weight management Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/368—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/362—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/48—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
- A23G3/54—Composite products, e.g. layered, coated, filled
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
- A23G3/54—Composite products, e.g. layered, coated, filled
- A23G3/545—Composite products, e.g. layered, coated, filled hollow products, e.g. with inedible or edible filling, fixed or movable within the cavity
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/064—Chewing gum characterised by the composition containing organic or inorganic compounds containing inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/068—Chewing gum characterised by the composition containing organic or inorganic compounds containing plants or parts thereof, e.g. fruits, seeds, extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
- A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G4/126—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
- A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/18—Chewing gum characterised by shape, structure or physical form, e.g. aerated products
- A23G4/20—Composite products, e.g. centre-filled, multi-layer, laminated
- A23G4/205—Hollow products, e.g. with inedible or edible filling, fixed or movable within the cavity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention is directed to a diet weight control gum, sucker (e g , lollipop) and lozenge, and more particularly, to a gum and/or sucker and/or lozenge that has at least an exterior and an interior component, having distinct metabolic and functional characteristics designed to appeal to weight conscious individuals endeavoring to lose weight
- Obesity is a serious public health hazard, second in importance only to tobacco Approximately 1/3 of Americans are seriously overweight according to life insurance data In approximately 12 million Americans, obesity significantly contributes toward the cause and complications of se ⁇ ous disease Such conditions include heart and lung disease, many types of cancer, diabetes, high blood pressure, and peripheral arterial disease This is m addition to how obesity becomes a cosmetic problem Being overly fat limits both length of life and its quality A multi-billion dollar industry has developed in an effort to control weight. The many varied and expensive techniques employed speak to the relative ineffectiveness of the many techniques that have been tried to get rid of excess fat.
- Obesity has recently been recognized as a public health hazard of epidemic proportions by the World Health Organization.
- One of three Americans between the ages of 20-74 are obese (Body Mass Index > 30 Kg/m 2 body surface). This amounts to 58 million people. The number of obese adults has increased dramatically. In 1980 25% of US adults were obese. The equivalent figure was 33 % in 1990. In Europe the equivalent figure is about 40%.
- Obesity significantly contributes to the dangers of other diseases in approximately half of those who exceed the threshold description of obesity. For example, 19% of the cost of management of heart disease can be ascribed to obesity.
- Obesity is also recognized as a co-morbid factor for obese patients suffering from degenerative arthritis, peripheral vascular disease, and many forms of pulmonary disease such as emphysema.
- the expenditure for products, goods, and services in the management of obesity is estimated to be $ 33 billion per year. This is 3%-4% of total health care expenditure per year and exceeds that expended for AIDS and cancer.
- Obesity is such a prevalent, important and distressing problem that its many methods for suggested management are too well known to deserve more than listing. They include diets that exclude fats and high caloric elements, food supplements, appetite suppressants, exercise machines and regimes, biofeedback and other psychotherapeutic techniques, and a variety of operative techniques. Operations include a number of methods for decreasing the capacity the stomach, gastric by-pass operations, methods to shorten the small intestinal absorption surface, excision of the unwanted fat (lipectomy) and techniques of liposuction. Liposuction is performed approximately 51,000 times each year in the US. The maximum amount of fat that can safely be removed is approximately 2 Kg.
- Weight control systems and methods have improved over the years. Indeed, the ancient Romans believed that the vomito ⁇ um was penance for their uncontrollable feasting and drinking during long celebrations for their various deities. Modern methods of weight control including arduous and sometimes playful workout routines and machines are no less peculiar in modern times Moreover, with the advent of liposuction, stomach stapling, etc., there appears to be no bounds beyond which humans will go to attain desired physical characteristics as such relate to their weight. The effect of such weight norms has created a $60 billion a year market for diet and weight control products.
- the present invention is directed to a method and product which provides a weight control substance to an individual other than through the consumption of pills, suppositories, diet beverages and/or tasteless and low caloric foodstuffs
- the present invention is directed to a particular gum product having at its center a composition different from the surrounding gum and having distinct functional and metabolic characteristics
- various metabolism increasing components can be provided in the interior of a gum in a liquid or semi-liquid form while the gum itself can be of a traditional gum composition and/or may inco ⁇ orate various other desirable metabolic increasing components to supplement and/or coact with components contained in the liquid center of the gum
- time release capsules may be provided suspended in a liquid medium inside a gum enclosure Chewing of the gum-based product releases the interior liquid substance, thus providing a product and a
- Yet another embodiment of the present invention relates to a hard candy substance (e.g. primarily comprising a natural sugar and corn syrup base)often referred to as a "sucker" or "lollipop."
- a hard candy substance e.g. primarily comprising a natural sugar and corn syrup base
- the interior of the sucker or lollipop contains a less rigid, soft and/or liquid or semi-liquid component.
- the enclosed material of the lollipop includes metabolic enhancers for weight and caloric control.
- a lozenge in still another embodiment, can be manufactured having a denser exterior and a less dense interior, where either the interior or exterior of the lozenge, or both, contain diet controlling substances.
- diet controlling substances are positioned within the interior of such lozenges so as to facilitate the enjoyment by an individual of consuming the lozenge without the possible unpleasant and/or undesirable taste characteristics of various dietary components within the center of the lozenge.
- pu ⁇ ose of the present invention is to increase metabolic efficiency and to burn calories in an individual.
- Herbal additives may be inco ⁇ orated into such products to aid in the body's ability to digest food and/or to block abso ⁇ tion of fat molecules into the system.
- chitosan compositions can be utilized either in the interior and/or exterior of the gum, lollipop and lozenge embodiments desired above and hereafter.
- other fiber-like components, vitamins and minerals e.g., especially calcium compositions to treat osteoporosis
- While the present invention is primarily directed to administering diet control substances to individuals, it should be understood that other medicinal and/or nutritional and/or biological components can be administered to animals in general (companion pets, livestock, etc.) but preferably humans. Indeed, the present inventor believes that the administration of medicinal compounds to young children can be greatly facilitated by use of the present invention given that children are more apt to take medicine in the form of a lollipop, lozenge or gum, particularly if the taste and flavor and textural characteristics of such candy products are preserved and effective amounts of desired components are delivered to such individuals when consuming such products.
- Fig. 1 represents one embodiment of the invention depicting both a gum-based outer shell and a liquid or syrup center, both consisting of all or some ingredients listed in Table I or Table II.
- Fig. 2 represents another embodiment of the present invention in a lollipop form.
- the following table contains a list of possible components that may be mco ⁇ orated into the center of the gum, lollipop and lozenge aspects of the present invention-
- compositions, formulations, masking agents e.g., to "mask” unpleasant flavors and/or textures and/or mouth feel characteristics of vitamins, medicinal compounds, minerals, etc.
- binders can be combined with the present structure of the present invention to achieve various desired pu ⁇ oses.
- controlled release formulations are encompassed by the present invention as are the preparation and use of various different carrier vehicles useful for medicinally administering compositions to animals, time release formulations, compositions having desirable solubility and dissolution rates, and the inco ⁇ oration into the present invention of food additives such as vitamins, pharmaceutical preparations and other compounds, specifically those that reduce the abso ⁇ tion of pids such a chitosan.
- Both the gum with liquid-type fillers and the sucker with a gum-based center can be comprised of one or more of the following- xanthan, guar, locust bean gum, karaya, gum tragacanth, carrageenans, algmates, gum arable, corn syrup, sugar, starches, gum bases. While multiple recipes exist, most candy substances can also be made from natural and herbal substitutes listed in Table II.
- the cavities that are extruded m both the gum and the lollipop can be made with one or more cavities that can be filled with multiple bio-enhancing and weight management substances, compiling all or some of the properties in Table II. The combination of them will achieve various results.
- Chitosan The amounts of all or some of these ingredients can vary between no less than about .05 mg to more than about 30 mg.
- the size of the gum exterior can be made of a size less than 4.5 grams to more than 18.4 grams with the cavity center being able to accommodate a volume between .5 mg to more than 5 grams.
- the lollipop can be a total size of less than .65 oz. with the cavity center being a volume of no more than .42 oz. and no less than 4.5 grams, to a size larger than 1.35 oz. with a cavity center being of at least 19 grams.
Abstract
A gum, lollipop and lozenge having at least two separate components, the first component having desirable taste characteristics and the second component having a diet control composition incorporated therein.
Description
DIET AND WEIGHT CONTROL GUM AND SUCKER
FIELD OF THE INVENTION
The present invention is directed to a diet weight control gum, sucker (e g , lollipop) and lozenge, and more particularly, to a gum and/or sucker and/or lozenge that has at least an exterior and an interior component, having distinct metabolic and functional characteristics designed to appeal to weight conscious individuals endeavoring to lose weight
BACKGROUND OF THE INVENTION
Throughout the ages, human beings have attempted to attain and maintain particular body morphologies, and in particular, have attempted to control their weight so as to conform with then-fashionable mores During the recent past, a preference for less massive morphologies has been in vogue and a populous genetically ill-equipped to conform with such weight characteristics is bombarded with images of svelte figures m both male and female forms
The desire of individuals to lose weight and specifically, to lose fatty tissue, has become nearly an obsession in the United States and many other countries Any simple and safe method toward achieving a slim figure is in great demand Methods for losing weight include hundreds of advtsed diets, machines and methods for exercise, various psychiatric techniques involving alteration in mental attitudes, and a variety of surgical techniques Liposuction has created an entirely new surgical cosmetic industry, but carries a small but significant risk and often leaves the patient with an unsightly cosmetic result due to the inflammatory reaction surrounding where the fatty tissue has been removed by a technique which produces a severe tissue reaction
Obesity is a serious public health hazard, second in importance only to tobacco Approximately 1/3 of Americans are seriously overweight according to life insurance data In approximately 12 million Americans, obesity significantly contributes toward the cause and complications of seπous disease Such conditions include heart and lung disease, many types of cancer, diabetes, high blood pressure, and peripheral arterial disease This is m addition to how obesity becomes a cosmetic problem Being overly fat limits both length of life and its quality
A multi-billion dollar industry has developed in an effort to control weight. The many varied and expensive techniques employed speak to the relative ineffectiveness of the many techniques that have been tried to get rid of excess fat.
Obesity has recently been recognized as a public health hazard of epidemic proportions by the World Health Organization. One of three Americans between the ages of 20-74 are obese (Body Mass Index > 30 Kg/m2 body surface). This amounts to 58 million people. The number of obese adults has increased dramatically. In 1980 25% of US adults were obese. The equivalent figure was 33 % in 1990. In Europe the equivalent figure is about 40%. Obesity significantly contributes to the dangers of other diseases in approximately half of those who exceed the threshold description of obesity. For example, 19% of the cost of management of heart disease can be ascribed to obesity. Obesity is also recognized as a co-morbid factor for obese patients suffering from degenerative arthritis, peripheral vascular disease, and many forms of pulmonary disease such as emphysema. The expenditure for products, goods, and services in the management of obesity is estimated to be $ 33 billion per year. This is 3%-4% of total health care expenditure per year and exceeds that expended for AIDS and cancer.
Obesity is such a prevalent, important and distressing problem that its many methods for suggested management are too well known to deserve more than listing. They include diets that exclude fats and high caloric elements, food supplements, appetite suppressants, exercise machines and regimes, biofeedback and other psychotherapeutic techniques, and a variety of operative techniques. Operations include a number of methods for decreasing the capacity the stomach, gastric by-pass operations, methods to shorten the small intestinal absorption surface, excision of the unwanted fat (lipectomy) and techniques of liposuction. Liposuction is performed approximately 51,000 times each year in the US. The maximum amount of fat that can safely be removed is approximately 2 Kg. Being an operative technique for removing fat, in this case by suction, it inevitably excites an inflammatory response at the operative site, which results not only in post operative inflammation but in subsequent uneven and unsightly scarring beneath the skin where the fat has been removed.
Incorporated by reference in its entirety are the following U.S. patents directed generally to chewing gum compositions, methods and apparatus for making chewing gum, and in particular, methods for enabling one of skill in the art to produce soft- centered chewing gums as contemplated by the present invention The novelty of the present invention, however, should be understood as being distinguished from such prior art references and such incorporation by reference is only provided for enabling support of the numerous ways in which the particular novel product can be manufactured. The U.S. patents incorporated by reference are as follows 5,922,347; 5,916,606; 5,912,030,
5,900,230 5,885,630, 5,866,179; 5,858,423, 5,846,557; 5,834,002; 5,827,526, 5,824,291 5,736,175, 4,156,740, 5,498,429; 4,466,983; 4,157,402; 5,569,477, 5,125,819 5,248,508, 4,975,288, 4,792,453; 4,980,178; 4,683,138; 5,087,460; 4,292,329 4,642,235, 4,316,915; 4,513,012, 4,250,196; 5,431,929; and 4,647,450.
Weight control systems and methods have improved over the years. Indeed, the ancient Romans believed that the vomitoπum was penance for their uncontrollable feasting and drinking during long celebrations for their various deities. Modern methods of weight control including arduous and sometimes bizarre workout routines and machines are no less peculiar in modern times Moreover, with the advent of liposuction, stomach stapling, etc., there appears to be no bounds beyond which humans will go to attain desired physical characteristics as such relate to their weight. The effect of such weight norms has created a $60 billion a year market for diet and weight control products. It is estimated that nearly half of all American women, and a quarter of all men, are on a diet at any given time As is well known, however, most diets, studies have shown, do not work for nine out of ten people who, after suffering through such diets, quickly regain their weight and often exceed their previous body mass. Such an unfortunate volley of feasting and dieting leads not only to physical harm due to increased rates of diabetes, arterial sclerosis, and other physical health problems, but also to an often devastating decreased estimation of a person's self-worth.
There is thus a long felt but unsolved need for an effective, inexpensive and easy way in which to provide health conscious individuals with diet products to assist in achieving desired weight loss
SUMMARY OF THE INVENTION The present invention is directed to a method and product which provides a weight control substance to an individual other than through the consumption of pills, suppositories, diet beverages and/or tasteless and low caloric foodstuffs In one embodiment, the present invention is directed to a particular gum product having at its center a composition different from the surrounding gum and having distinct functional and metabolic characteristics For example, various metabolism increasing components can be provided in the interior of a gum in a liquid or semi-liquid form while the gum itself can be of a traditional gum composition and/or may incoφorate various other desirable metabolic increasing components to supplement and/or coact with components contained in the liquid center of the gum Indeed, in one particular embodiment of the present invention, time release capsules may be provided suspended in a liquid medium inside a gum enclosure Chewing of the gum-based product releases the interior liquid substance, thus providing a product and a method desirable by weight conscious individuals who do not wish to publicly announce or disclose their dietary desires In a preferred embodiment, the substance contained within the gum (e g the interior liquid substance) would have as a principal characteristic the capability of increasing a user's caloric burn rate (e g by increasing a person' s metabolism, adjusting/regulating hormonal activity in an individual, providing fiber to increase a person's feelings of satiety) In a particular embodiment of the present invention, a gum is utilized having liquid interior components surrounded by the dense gum, for example, the interior having a density less than 10% as dense as the exterior gum, more preferably at least about 15% less dense, and more preferably, at least about 35% less dense than the surrounding gum The interior liquid components can be herbal, organic, natural, chemical and/or hormonal in nature, and may be selected dependent upon their individual and synergistic characteristics, with the objective being to increase a person's metabolism in order to achieve a higher caloric burn rate and/or to decrease the desire for additional food (e g generate a feeling of satiety or fullness) It is within the scope of the present invention to incoφorate various known diet control substances in either the gum material itself and/or in the liquid interior material encompassed by the gum material In a preferred embodiment, however, the surrounding gum material is comprised of traditional gum
flavors and compositions and the interior liquid and/or semi-liquid (e.g. gel) components of the present invention comprise diet regulating substances.
Yet another embodiment of the present invention relates to a hard candy substance (e.g. primarily comprising a natural sugar and corn syrup base)often referred to as a "sucker" or "lollipop." The interior of the sucker or lollipop, however, contains a less rigid, soft and/or liquid or semi-liquid component. The enclosed material of the lollipop includes metabolic enhancers for weight and caloric control.
In still another embodiment, a lozenge can be manufactured having a denser exterior and a less dense interior, where either the interior or exterior of the lozenge, or both, contain diet controlling substances. Preferably, diet controlling substances are positioned within the interior of such lozenges so as to facilitate the enjoyment by an individual of consuming the lozenge without the possible unpleasant and/or undesirable taste characteristics of various dietary components within the center of the lozenge.
It will be understood that the puφose of the present invention is to increase metabolic efficiency and to burn calories in an individual. Herbal additives may be incoφorated into such products to aid in the body's ability to digest food and/or to block absoφtion of fat molecules into the system. For example, chitosan compositions can be utilized either in the interior and/or exterior of the gum, lollipop and lozenge embodiments desired above and hereafter. In addition to chitosan, other fiber-like components, vitamins and minerals (e.g., especially calcium compositions to treat osteoporosis) can be incoφorated into the present invention to provide desired feelings of satiety or fullness to an individual using such products and/or to treat various vitamin and/or mineral deficiencies.
While the present invention is primarily directed to administering diet control substances to individuals, it should be understood that other medicinal and/or nutritional and/or biological components can be administered to animals in general (companion pets, livestock, etc.) but preferably humans. Indeed, the present inventor believes that the administration of medicinal compounds to young children can be greatly facilitated by use of the present invention given that children are more apt to take medicine in the form of a lollipop, lozenge or gum, particularly if the taste and flavor and textural
characteristics of such candy products are preserved and effective amounts of desired components are delivered to such individuals when consuming such products.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 represents one embodiment of the invention depicting both a gum-based outer shell and a liquid or syrup center, both consisting of all or some ingredients listed in Table I or Table II.
Fig. 2 represents another embodiment of the present invention in a lollipop form.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
The following table contains a list of possible components that may be mcoφorated into the center of the gum, lollipop and lozenge aspects of the present invention-
TABLE I
The following U.S. issued patents are also incoφorated herein by reference1 5,474,989 by Hasimoto et al., 5,747,475 by Norqmst et al., 5,830,883 by Block et al , 5,880,109 by Nakamura et al., 4,963,367 by Ecanow, 4,738,850 by Thakur et al., 5,846,952 by Vournakis et al., and 4,223,023 by Furda. It will therefore be appreciated by one of skill in the art that various compositions, formulations, masking agents (e.g., to "mask" unpleasant flavors and/or textures and/or mouth feel characteristics of vitamins, medicinal compounds, minerals, etc.) and binders can be combined with the present structure of the present invention to achieve various desired puφoses. For
example, controlled release formulations are encompassed by the present invention as are the preparation and use of various different carrier vehicles useful for medicinally administering compositions to animals, time release formulations, compositions having desirable solubility and dissolution rates, and the incoφoration into the present invention of food additives such as vitamins, pharmaceutical preparations and other compounds, specifically those that reduce the absoφtion of pids such a chitosan.
Both the gum with liquid-type fillers and the sucker with a gum-based center can be comprised of one or more of the following- xanthan, guar, locust bean gum, karaya, gum tragacanth, carrageenans, algmates, gum arable, corn syrup, sugar, starches, gum bases. While multiple recipes exist, most candy substances can also be made from natural and herbal substitutes listed in Table II. The cavities that are extruded m both the gum and the lollipop can be made with one or more cavities that can be filled with multiple bio-enhancing and weight management substances, compiling all or some of the properties in Table II. The combination of them will achieve various results. Example: Guarana and malluang and chitosan will create energy and a feeling of "fullness" for the consumer; chromium picolinate (RE. 33, 988) and ginseng and ginger will allow the user to burn calories more efficiently).
TABLE II
Siberian Ginseng Vitamin E Green Tea Zinc
Casgara Sagrada Mahuang
Apple Pectin Astragalus
Dandelion Guarana
Chickweek Bee Pollen Gymnema Sylvestre Chromium Picolinate
Licorice Bluegreen Algae
Bladderwrack Royal Jelly
Ginger Damiana
Magnesium Lecithin Sarsapaπlla Gotu Kola
Golden Seal Nettles
Chitosan
The amounts of all or some of these ingredients can vary between no less than about .05 mg to more than about 30 mg. The size of the gum exterior can be made of a size less than 4.5 grams to more than 18.4 grams with the cavity center being able to accommodate a volume between .5 mg to more than 5 grams. The lollipop can be a total size of less than .65 oz. with the cavity center being a volume of no more than .42 oz. and no less than 4.5 grams, to a size larger than 1.35 oz. with a cavity center being of at least 19 grams.
While various embodiments of the present invention have been described in detail, it is apparent that further modifications and adaptations of the invention will occur to those skilled in the art. However, it is to be expressly understood that such modifications and adaptations are within the spirit and scope of the present invention.
Claims
1. An edible product for use in diet control, comprising: a) a first substance comprised of gum configured so as to have at least one cavity capable of retaining a liquid or semi-liquid component; b) a second component comprising a liquid or semi-liquid contained in said at least one cavity within said gum; c) wherein said second component comprises a diet control substance that has a density less than the density of said first substance.
2 An edible product for use in diet control, comprising- a) a first substance comprised of a hard candy configured so as to have at least one cavity capable of retaining a liquid or semi-liquid component; b) a second component comprising a liquid or semi-liquid contained in said at least one cavity within said hard candy; c) wherein said second component comprises a diet control substance and that has a mass less than the mass of said first substance.
3. An edible product for use in diet control, comprising: a) a first substance comprised of a lozenge configured so as to have at least one cavity capable of retaining a liquid or semi-hquid component; b) a second component comprising a liquid or semi-hquid contained in said at least one cavity within said lozenge; c) wherein said second component comprises a diet control substance and that has a mass and a density less than the density and mass of said first substance.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU38852/01A AU3885201A (en) | 1999-09-20 | 2000-09-19 | Diet and weight control gum and sucker |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15497299P | 1999-09-20 | 1999-09-20 | |
US60/154,972 | 1999-09-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001021147A1 true WO2001021147A1 (en) | 2001-03-29 |
Family
ID=22553603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/025608 WO2001021147A1 (en) | 1999-09-20 | 2000-09-19 | Diet and weight control gum and sucker |
Country Status (3)
Country | Link |
---|---|
US (5) | US6491540B1 (en) |
AU (1) | AU3885201A (en) |
WO (1) | WO2001021147A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2625965C2 (en) * | 2011-12-16 | 2017-07-20 | Вм. Ригли Дж. Компани | Chewing gum and method for its manufacturing |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9253991B2 (en) | 1999-09-20 | 2016-02-09 | Jack Barreca | Chewing gum with B vitamins |
AU3885201A (en) | 1999-09-20 | 2001-04-24 | Mastercare | Diet and weight control gum and sucker |
US9387168B2 (en) | 1999-09-20 | 2016-07-12 | Jack Barreca | Chewing gum with tomatidine |
US6838098B2 (en) * | 2000-09-07 | 2005-01-04 | Cadbury Adams Usa, Llc | Continuous formation of center filled gum |
US6623266B2 (en) * | 2001-01-19 | 2003-09-23 | Cadbury Adams Usa Llc | Apparatus for making a center-filled gum lollipop with hard candy shell |
US6966622B2 (en) * | 2001-09-28 | 2005-11-22 | Hewlett-Packard Development Company, L.P. | Thermal sense resistor for a replaceable printer component |
ITMI20012320A1 (en) * | 2001-11-06 | 2003-05-06 | Perfetti Van Melle Spa | ORAL COMPOSITIONS SOLID ANTI-TARTAR AND ANTI-BACTERIAL PLATE, USEFUL AS ADJUVANTS IN DENTISTRY-STOMATOLOGICAL HYGIENE |
ITMI20012322A1 (en) * | 2001-11-06 | 2003-05-06 | Perfetti Van Melle Spa | ORAL COMPOSITIONS SOLID ANTI-TARTAR AND ANTI-BACTERIAL PLATE, USEFUL AS ADJUVANTS IN ODONT-STOMATOLOGICAL HYGIENE |
US7244455B2 (en) * | 2002-01-16 | 2007-07-17 | Warner-Lambert Company | Center-filled chewing gum containing a deliverable form of calcium |
PL218910B1 (en) * | 2002-09-28 | 2015-02-27 | Pharmaton Sa | Composition comprising panax ginseng and paullinia cupana extracts |
US8602774B2 (en) | 2002-12-04 | 2013-12-10 | Bryan Wasylucha | Process of tooth whitening and apparatus therefor |
US6982098B1 (en) | 2003-05-30 | 2006-01-03 | Fun Unlimited Inc. | Nutritional weight loss agent and method |
US20050053555A1 (en) * | 2003-07-14 | 2005-03-10 | Crave Busters, Llc. | Appetite control compositions and methods of use |
EP1656153A2 (en) * | 2003-07-14 | 2006-05-17 | Crave Busters, Llc. | Appetite control compositions and methods of use |
US20050045197A1 (en) * | 2003-08-28 | 2005-03-03 | Gelder Steven K. | Multiple drug delivery system & method |
GB0326492D0 (en) * | 2003-11-14 | 2003-12-17 | Cadbury Schweppes Plc | Liquid-filled confectionery compositions |
US20050250736A1 (en) * | 2004-05-10 | 2005-11-10 | Michael Cherkassky | Composition and method for treatment of obesity and smoking cessation |
US20060018842A1 (en) * | 2004-06-25 | 2006-01-26 | Gary Blumenthal | Composition and method for delivery of phytochemicals |
WO2007136375A2 (en) * | 2005-05-23 | 2007-11-29 | Cadbury Adams Usa Llc | Package assembly for multi-modality taste chewing gum compositions |
WO2006026298A2 (en) * | 2004-08-25 | 2006-03-09 | Cadbury Adams Usa Llc | Liquid-filled chewing gum composition |
US20060280837A1 (en) * | 2004-08-25 | 2006-12-14 | Cadbury Adams Usa Llc. | Multi-modality sensations in chewing gum compositions |
US20060286201A1 (en) * | 2004-08-25 | 2006-12-21 | Cadbury Adams Usa Llc. | Multi-modality functional ingredients in chewing gum compositions |
US20060280836A1 (en) * | 2004-08-25 | 2006-12-14 | Cadbury Adams Usa Llc. | Multi-modality tastes in chewing gum compositions |
US20060263476A1 (en) * | 2004-08-25 | 2006-11-23 | Cadbury Adams Usa, Llc. | Center-filled chewing gum with barrier layer |
US7727565B2 (en) * | 2004-08-25 | 2010-06-01 | Cadbury Adams Usa Llc | Liquid-filled chewing gum composition |
US20070148286A1 (en) * | 2004-08-25 | 2007-06-28 | Cadbury Adams Usa Llc. | Liquid-filled chewing gum composition |
US20060280835A1 (en) * | 2004-08-25 | 2006-12-14 | Cadbury Adams Usa Llc. | Multi-modality flavored chewing gum compositions |
US7641926B2 (en) * | 2004-08-25 | 2010-01-05 | Cadbury Adams Usa, Llc | Liquid-filled chewing gum composition |
US20060280834A1 (en) * | 2004-08-25 | 2006-12-14 | Cadbury Adams Usa, Llc. | Center-filled chewing gum composition |
US20070148284A1 (en) * | 2004-08-25 | 2007-06-28 | Cadbury Adams Usa Llc. | Liquid-filled chewing gum |
US20060263475A1 (en) * | 2004-08-25 | 2006-11-23 | Cadbury Adams Usa, Llc. | Center-filled chewing gum composition |
US20060153949A1 (en) * | 2005-01-11 | 2006-07-13 | Cadbury Adams Usa Llc. | Edible compositions containing swellable polymers |
EP1906746A4 (en) * | 2005-05-23 | 2011-09-21 | Cadbury Adams Usa Llc | Liquid-filled chewing gum composition |
KR100568578B1 (en) * | 2005-05-25 | 2006-04-07 | 신승희 | Nourishment gum and preparing method thereof |
GB0520956D0 (en) * | 2005-10-14 | 2005-11-23 | Med Eq As | Chewing gum |
US7989009B2 (en) * | 2006-02-02 | 2011-08-02 | Advocare International, L.P. | Composition and method for promoting weight loss |
US20070178176A1 (en) * | 2006-02-02 | 2007-08-02 | Chithan Kandaswami | Composition and method for promoting weight loss |
MX2008012523A (en) * | 2006-04-05 | 2008-10-14 | Cadbury Adams Usa Llc | Calcium phosphate complex in acid containing chewing gum. |
RU2421207C2 (en) | 2006-04-05 | 2011-06-20 | КЭДБЕРИ АДАМС ЮЭсЭй ЛЛС | Oral composition for improving subsurface remineralisation of denal enamel in mammal |
US20070292566A1 (en) * | 2006-06-16 | 2007-12-20 | Degennaro Sergio K | Edible spoon for administering liquid medications |
RU2405371C2 (en) | 2006-06-29 | 2010-12-10 | КЭДБЕРИ АДАМС ЮЭсЭй ЛЛС | Chain-drive cutting machine for continuous formating of chewing gum with central filler |
US20080063748A1 (en) * | 2006-09-08 | 2008-03-13 | Cadbury Adams Usa Llc. | Center-fill confectionery and chewing gum compositions containing suspended saccharide particles |
US20090004248A1 (en) * | 2007-06-29 | 2009-01-01 | Frank Bunick | Dual portion dosage lozenge form |
ES2704409T5 (en) * | 2007-07-27 | 2022-03-25 | Intercontinental Great Brands Llc | Method and apparatus for processing confectionery |
DK2373179T3 (en) * | 2008-12-19 | 2018-11-26 | Fertin Pharma As | MULTIPLE KIT comprising a chewing gum and a further flavoring-containing formulation |
US20100247586A1 (en) * | 2009-03-27 | 2010-09-30 | Andreas Hugerth | Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties |
CN102458143A (en) * | 2009-05-01 | 2012-05-16 | 巴斯夫公司 | Chlorine dioxide based gum and candy |
WO2012019140A2 (en) * | 2010-08-05 | 2012-02-09 | Wm. Wrigley Jr. Company | Nonlinear rheology of chewing gum and gum base |
ES2388281B1 (en) * | 2010-12-27 | 2013-10-01 | Laboratorios Viñas S.A. | Pharmaceutical composition comprising hyaluronic acid and a zinc compound and stick with stick and corresponding preparation procedure |
WO2016130830A1 (en) | 2015-02-11 | 2016-08-18 | The Fix, Llc | Compositions and methods for combination ingredient delivery |
US10532046B2 (en) | 2015-12-03 | 2020-01-14 | Niconovum Usa, Inc. | Multi-phase delivery compositions and products incorporating such compositions |
USD880809S1 (en) | 2018-12-11 | 2020-04-14 | Mars, Incorporated | Pet treat |
USD880808S1 (en) | 2018-12-11 | 2020-04-14 | Mars, Incorporated | Pet treat |
USD880807S1 (en) | 2018-12-11 | 2020-04-14 | Mars, Incorporated | Pet treat |
USD890466S1 (en) * | 2019-03-25 | 2020-07-21 | Stephen Caldwell | Stuffed fritter |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4980178A (en) * | 1986-12-10 | 1990-12-25 | Warner-Lambert Company | Reduced calorie center-filled chewing gum compositions having improved stability |
US5409905A (en) * | 1981-01-05 | 1995-04-25 | Eby, Iii; George A. | Cure for commond cold |
US5891422A (en) * | 1996-10-10 | 1999-04-06 | Warner-Lambert Company | Antimicrobial composition containing a C3 -C6 alcohol |
Family Cites Families (243)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3029189A (en) * | 1962-04-10 | S-aryl-z-mno-x-qxazolibinones | ||
US1298670A (en) * | 1915-06-11 | 1919-04-01 | Stuart W Cramer | Chewing-gum. |
US1629461A (en) * | 1926-04-22 | 1927-05-17 | Health Products Corp | Chewing gum |
US2892753A (en) | 1957-02-26 | 1959-06-30 | Boehringer Sohn Ingelheim | Central nervous system stimulant |
BE585778A (en) | 1958-04-18 | |||
US3011949A (en) | 1958-06-10 | 1961-12-05 | Anthony G Bilotti | Method of promoting release of active ingredients from slab chewing gum and product |
US3047461A (en) | 1960-06-10 | 1962-07-31 | American Cyanamid Co | Central nervous system stimulant |
US3075884A (en) * | 1961-02-13 | 1963-01-29 | American Chicle Co | Slab chewing gums containing active ingredients and method of preparing same |
US3196172A (en) | 1963-05-20 | 1965-07-20 | American Cyanamid Co | Trifluoromethylphenylalkylenediamines |
DE1216486B (en) * | 1964-04-23 | 1966-05-12 | Merck Ag E | Process for the production of coated tablets |
US3308022A (en) * | 1964-06-25 | 1967-03-07 | American Cyanamid Co | Novel hypotensive compositions containing 1-substituted-3-cyano guanidines |
US3498964A (en) * | 1966-08-29 | 1970-03-03 | Takashi Hayashi | Peripheral vasodilator peptide obtained from the animals of the family otariidae and method of preparing the same |
US3590057A (en) | 1967-12-21 | 1971-06-29 | Sumitomo Chemical Co | (alpha-(c5-c17)alkyl)benzyl fatty acid amides as cholesterol lowering agents |
US3877468A (en) * | 1970-07-22 | 1975-04-15 | Leo Ab | Chewable tobacco substitute composition |
US3901248A (en) | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
US3845217A (en) | 1972-11-16 | 1974-10-29 | Helsingborg L Ab | Buffered smoking substitute compositions |
US3894154A (en) * | 1974-01-14 | 1975-07-08 | Warner Lambert Co | Center-filled gum |
US3995064A (en) | 1975-06-04 | 1976-11-30 | Life Savers, Inc. | Method and apparatus for forming chewing gum base and product |
US4150161A (en) * | 1977-03-15 | 1979-04-17 | General Foods Corporation | Carbonated chewing gum |
JPS5939099B2 (en) | 1977-11-22 | 1984-09-20 | 株式会社ロツテ | Method for enhancing flavor retention of chewing gum with center |
US4156740A (en) | 1978-02-02 | 1979-05-29 | Warner-Lambert Company | Sugarless center-filled chewing gum |
US4292329A (en) | 1978-02-06 | 1981-09-29 | Lotte Co., Ltd. | Center-filled chewing gum |
US4154814A (en) * | 1978-02-13 | 1979-05-15 | EPS Chewing Gum, Inc. | Therapeutic chewing gum |
US4223023A (en) | 1978-10-12 | 1980-09-16 | Ivan Furda | Nonabsorbable lipid binder |
US4238510A (en) | 1979-02-21 | 1980-12-09 | Life Savers, Inc. | Sugarless coating for chewing gum and confections and method |
JPS6056143B2 (en) | 1979-08-02 | 1985-12-09 | 山之内製薬株式会社 | Amidine derivatives and their production method |
US4238475A (en) | 1979-08-01 | 1980-12-09 | Life Savers Inc. | Chewing cum capable of releasing finely divided water-insoluble materials therefrom |
US4250195A (en) * | 1979-09-24 | 1981-02-10 | Life Savers, Inc. | Method for applying soft flexible sugar coating to fresh chewing gum and coated chewing gum product |
US4317838A (en) * | 1979-09-24 | 1982-03-02 | Life Savers, Inc. | Method for applying sugarless coating to chewing gum and confections |
US4316915A (en) * | 1979-10-01 | 1982-02-23 | Life Savers, Inc. | Center-filled chewing gums |
US4374858A (en) * | 1979-10-04 | 1983-02-22 | Warner-Lambert Company | Aspartame sweetened chewing gum of improved sweetness stability |
US4250196A (en) | 1979-10-09 | 1981-02-10 | Life Savers, Inc. | Center-filled chewing gums |
US4386063A (en) * | 1980-12-18 | 1983-05-31 | International Flavors & Fragrances Inc. | Flavor use of mixtures containing 1-n-butoxy-1-ethanol acetate |
US4400372A (en) | 1981-03-05 | 1983-08-23 | Indiana University Foundation | Chewing gum |
US4372942A (en) * | 1981-08-13 | 1983-02-08 | Beecham Inc. | Candy base and liquid center hard candy made therefrom |
US4386106A (en) * | 1981-12-01 | 1983-05-31 | Borden, Inc. | Process for preparing a time delayed release flavorant and an improved flavored chewing gum composition |
US4452821A (en) | 1981-12-18 | 1984-06-05 | Gerhard Gergely | Confectionery product, particularly chewing gum, and process for its manufacture |
US4378374A (en) * | 1981-12-21 | 1983-03-29 | Nabisco Brands, Inc. | Chewing gum having improved softness |
DE3332429T1 (en) | 1982-02-22 | 1984-01-26 | Belorusskij naučno-issledovatel'skij sanitarno-gigieničeskij institut, 220012 Minsk | MEDICINAL PRODUCT WITH ANTINICOTINE EFFECT AND METHOD FOR THE PRODUCTION THEREOF |
DE3213284A1 (en) | 1982-04-08 | 1983-10-13 | Winfried 8451 Kümmersbruck Kruppa | ANTI-CARIES CHEWING GUM |
US4446135A (en) * | 1982-06-07 | 1984-05-01 | Sterling Drug Inc. | Chewable antacid tablets |
JPS5925646A (en) | 1982-07-30 | 1984-02-09 | Lotte Co Ltd | Chewing gum for preventing sleepiness |
JPS5966841A (en) * | 1982-10-05 | 1984-04-16 | Meiji Seika Kaisha Ltd | Preparation of conjugate fibrous chewing gum |
US4512968A (en) * | 1982-11-30 | 1985-04-23 | Lion Corporation | Oral compositions |
US4459311A (en) | 1983-01-03 | 1984-07-10 | Nabisco Brands, Inc. | Process for preparing gum base |
US4466983A (en) | 1983-02-04 | 1984-08-21 | Warner-Lambert Company | Substantially non-aqueous semi-liquid center-fill |
FR2540707A1 (en) | 1983-02-16 | 1984-08-17 | Hugues Coffinet | Chewing gum containing ginseng |
US4513012A (en) | 1983-05-13 | 1985-04-23 | Warner-Lambert Company | Powdered center-filled chewing gum compositions |
US4533556A (en) | 1983-06-14 | 1985-08-06 | Warner-Lambert Company | Kola flavored chewing gum and preparation thereof |
US4647450A (en) | 1983-07-20 | 1987-03-03 | Warner-Lambert Company | Chewing gum compositions containing magnesium trisilicate absorbates |
US4933184A (en) | 1983-12-22 | 1990-06-12 | American Home Products Corp. (Del) | Menthol enhancement of transdermal drug delivery |
US4563345A (en) * | 1984-01-23 | 1986-01-07 | Arrick Robert A | Chewing gum |
US4753805A (en) | 1984-01-31 | 1988-06-28 | Warner-Lambert Company | Tabletted chewing gum composition and method of preparation |
US4971806A (en) * | 1984-01-31 | 1990-11-20 | Warner-Lambert Company | Multi-layered chewing gum composition having different rates of flavor release |
US4963367A (en) | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
US4639368A (en) * | 1984-08-23 | 1987-01-27 | Farmacon Research Corporation | Chewing gum containing a medicament and taste maskers |
US4971787A (en) | 1984-08-27 | 1990-11-20 | Warner-Lambert Company | Antacid chewing gum |
US4929508A (en) * | 1984-10-05 | 1990-05-29 | Warner-Lambert Company | Novel drug delivery system for antitussives |
US4894234A (en) * | 1984-10-05 | 1990-01-16 | Sharma Shri C | Novel drug delivery system for antiarrhythmics |
US4935242A (en) | 1984-10-05 | 1990-06-19 | Warner-Lambert Company | Novel drug delivery system for expectorants |
US4642235A (en) * | 1984-10-26 | 1987-02-10 | Wm. Wrigley Jr. Company | Chewing gum with center fill comprising thaumatin or monellin and method |
US4555407A (en) | 1984-12-24 | 1985-11-26 | General Foods Corporation | Continuous chewing gum method |
JPH0796496B2 (en) * | 1984-12-27 | 1995-10-18 | ゲルゲリイ、ゲルハルト | Chewing gum and method for producing the same |
SE453822B (en) * | 1985-08-16 | 1988-03-07 | Plm Ab | CONTAINER WITH TWO LIDS |
GB8522453D0 (en) | 1985-09-11 | 1985-10-16 | Lilly Industries Ltd | Chewable capsules |
US4753800A (en) | 1985-10-04 | 1988-06-28 | Warner-Lambert Company | Medicament adsorbates and their preparation |
US4882152A (en) | 1985-12-20 | 1989-11-21 | Yang Robert K | Confectionery delivery system for laxatives, vitamins and antacids |
US4929447A (en) * | 1986-01-07 | 1990-05-29 | Warner-Lambert Company | Encapsulation composition for use with chewing gum and edible products |
US4849227A (en) | 1986-03-21 | 1989-07-18 | Eurasiam Laboratories, Inc. | Pharmaceutical compositions |
US4711774A (en) | 1986-03-27 | 1987-12-08 | Warner-Lambert Company | Medicament adsorbates with complex magnesium aluminum silicate and their preparation |
US4758424A (en) | 1986-03-27 | 1988-07-19 | Warner-Lambert Company | Medicament adsorbates of decongestants with complex magnesium aluminum silicate and their preparation |
US4716033A (en) | 1986-03-27 | 1987-12-29 | Warner-Lambert Company | Medicament adsorbates with surfactant and their preparation |
US4738850A (en) | 1986-05-27 | 1988-04-19 | E. R. Squibb & Sons, Inc. | Controlled release formulation and method |
US4683138A (en) | 1986-09-08 | 1987-07-28 | Warner-Lambert Company | Low moisture, sugarless, center-filled chewing gum |
US4908211A (en) * | 1986-09-08 | 1990-03-13 | Paz Armando F | Chewing gum and ingredients to chemically inhibit formation of plaque and calculus |
US4867989A (en) | 1986-09-09 | 1989-09-19 | Warner-Lambert Company | Chewing gum mineral supplement |
GB8630273D0 (en) | 1986-12-18 | 1987-01-28 | Til Medical Ltd | Pharmaceutical delivery systems |
US4828820A (en) * | 1987-01-15 | 1989-05-09 | Warner-Lambert Company | Chewable tooth cleaning composition |
US4835162A (en) * | 1987-02-12 | 1989-05-30 | Abood Leo G | Agonists and antagonists to nicotine as smoking deterents |
US5015464A (en) * | 1987-03-25 | 1991-05-14 | Amway Corporation | Antiplaque chewing gum |
US5070085A (en) | 1987-04-10 | 1991-12-03 | Oxycal Laboratories, Inc. | Compositions and methods for administering therapeutically active compounds |
US4968716A (en) | 1987-04-10 | 1990-11-06 | Oxycal Laboratories, Inc. | Compositions and methods for administering therapeutically active compounds |
US4822816A (en) * | 1987-04-10 | 1989-04-18 | Oxycal Laboratories, Inc. | Compositions and methods for administering vitamin C |
US4975270A (en) | 1987-04-21 | 1990-12-04 | Nabisco Brands, Inc. | Elastomer encased active ingredients |
US4792453A (en) | 1987-05-04 | 1988-12-20 | Wm. Wrigley Jr. Company | Hard coated sugarless chewing gum |
IE59934B1 (en) | 1987-06-19 | 1994-05-04 | Elan Corp Plc | Liquid suspension for oral administration |
US4853212A (en) | 1987-07-13 | 1989-08-01 | Warner-Lambert Company | Reduced base content chewing gum compositions having anesthetic properties |
US4822597A (en) * | 1987-07-13 | 1989-04-18 | Warner-Lambert Company | Anesthetic-containing chewing gum compositions |
US4832994A (en) * | 1987-09-02 | 1989-05-23 | Fey Michael S | Anti-smoking oral composition |
US5125819A (en) | 1987-11-24 | 1992-06-30 | Warner-Lambert Company | Apparatus for making center-filled chewing gum |
US4975288A (en) | 1987-12-08 | 1990-12-04 | Warner-Lambert Company | Method for making center-filled chewing gum |
US5013716A (en) * | 1988-10-28 | 1991-05-07 | Warner-Lambert Company | Unpleasant taste masking compositions and methods for preparing same |
KR900007862A (en) * | 1988-11-10 | 1990-06-02 | 정보영 | Inhibitor of Glucan Synthesis of F-1, F-2 Fractionated by Sephadex G-50 from Cacao Bean Husk Extract |
US5474989A (en) | 1988-11-11 | 1995-12-12 | Kurita Water Industries, Ltd. | Drug composition |
US4938963A (en) | 1988-11-22 | 1990-07-03 | Parnell Pharmaceuticals, Inc. | Method and composition for treating xerostomia |
US5110608A (en) * | 1988-12-29 | 1992-05-05 | Warner-Lambert Company | Chewing gums having longer lasting sweetness |
US5154927A (en) | 1989-01-19 | 1992-10-13 | Wm. Wrigley Jr. Company | Gum composition containing dispersed porous beads containing active chewing gum ingredients and method |
US5139787A (en) | 1989-01-19 | 1992-08-18 | Wm. Wrigley Jr. Company | Gum composition containing dispersed porous beads containing active chewing gum ingredients and method |
US4963369A (en) | 1989-01-19 | 1990-10-16 | Wm. Wrigley Jr. Co. | Gum composition containing dispersed porous beads containing active chewing gum ingredients and method |
US4968511A (en) | 1989-03-10 | 1990-11-06 | Amelia Ronald P D | Composition and process for one-step chewing gum |
SE463189B (en) * | 1989-03-13 | 1990-10-22 | Eston Joensson | PREPARED PROVIDED TO BE ADDED TO AMALGAM FILLINGS IN TEMPERATURE, THEREFORE, TO PREVENT OR REDUCE THE EXPOSURE OF MERCURY SILVER OR MERCURY SILVER |
US4997659A (en) * | 1989-03-28 | 1991-03-05 | The Wm. Wrigley Jr. Company | Alitame stability in chewing gum by encapsulation |
US5139794A (en) | 1989-04-19 | 1992-08-18 | Wm. Wrigley Jr. Company | Use of encapsulated salts in chewing gum |
US4978537A (en) | 1989-04-19 | 1990-12-18 | Wm. Wrigley Jr. Company | Gradual release structures for chewing gum |
DK365389D0 (en) * | 1989-07-24 | 1989-07-24 | Fertin Lab As | ANTIFUNGAL CHEMICAL GUM PREPARATION |
US4997654A (en) * | 1989-08-14 | 1991-03-05 | Warner-Lambert Company | Method for increasing salivation for xerostomia patients |
JPH0383913A (en) | 1989-08-25 | 1991-04-09 | Lotte Co Ltd | Gum for preventing pyorrhea alveolaris |
DE3941490A1 (en) | 1989-12-15 | 1991-06-20 | Mederer Gmbh | Sweet e.g. for sports players providing minerals - comprising fruit-gum or chewing-gum core with sugar coating contg. minerals and salts |
US5512306A (en) * | 1992-06-19 | 1996-04-30 | Pharmica Ab | Smoking substitute |
US4975200A (en) * | 1990-01-05 | 1990-12-04 | The Dow Chemical Company | Potassium fluoride removal from potassium chloride |
US5077051A (en) * | 1990-04-10 | 1991-12-31 | Warner-Lambert Company | Sustained release of active agents from bioadhesive microcapsules |
US5045325A (en) | 1990-09-26 | 1991-09-03 | Warner-Lambert Company | Continuous production of chewing gum using corotating twin screw extruder |
US5488962A (en) * | 1990-10-10 | 1996-02-06 | Perfetti, S.P.A. | Chewing gum which is a substitute for tobacco smoke |
US5078460A (en) | 1990-11-16 | 1992-01-07 | Holsinger Melvin L | Portable work station |
JPH06102605B2 (en) * | 1990-11-19 | 1994-12-14 | 昭和薬品化工株式会社 | Dental test agent composition |
US5126151A (en) | 1991-01-24 | 1992-06-30 | Warner-Lambert Company | Encapsulation matrix |
DE4102629A1 (en) | 1991-01-30 | 1992-08-06 | Bayer Ag | PHARMACEUTICAL RUBBER WITH ACETYL SALICYLIC ACID |
US5179122A (en) * | 1991-02-11 | 1993-01-12 | Eastman Kodak Company | Nutritional supplement containing vitamin e |
US5629013A (en) | 1991-04-04 | 1997-05-13 | The Procter & Gamble Company | Chewable calcium carbonate antacid tablet compositions |
US5244670A (en) | 1991-04-04 | 1993-09-14 | The Procter & Gamble Company | Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress |
US5380535A (en) * | 1991-05-28 | 1995-01-10 | Geyer; Robert P. | Chewable drug-delivery compositions and methods for preparing the same |
US5221698A (en) | 1991-06-27 | 1993-06-22 | The Regents Of The University Of Michigan | Bioactive composition |
NZ243667A (en) * | 1991-08-02 | 1995-02-24 | Kurihara Yoshie | Chewing gum containing coated curculin derivative or fruit containing curculin |
CA2103163C (en) * | 1991-08-26 | 1998-10-20 | Mou-Ying Fu Lu | Compositions and methods for the sublingual or buccal administration of therapeutic agents |
WO1992008368A1 (en) | 1991-09-30 | 1992-05-29 | Wm. Wrigley Jr. Company | Chewing gum containing fructooligosaccharides |
EP0661966B1 (en) | 1991-12-17 | 2000-07-19 | Biovail Technologies Ltd. | Ulcer prevention and treatment composition and method |
GB9127150D0 (en) | 1991-12-20 | 1992-02-19 | Smithkline Beecham Plc | Novel treatment |
US5286500A (en) * | 1992-03-03 | 1994-02-15 | Wm. Wrigley Jr. Company | Wax-free chewing gum base |
US5248508A (en) | 1992-03-23 | 1993-09-28 | Wm. Wrigley Jr. Company | Hard coated gum with improved shelf life |
US5665406A (en) | 1992-03-23 | 1997-09-09 | Wm. Wrigley Jr. Company | Polyol coated chewing gum having improved shelf life and method of making |
DK0566174T3 (en) | 1992-03-26 | 1996-10-14 | Loders Croklaan Bv | Green gum matrix |
US5294449A (en) * | 1992-04-09 | 1994-03-15 | Wm. Wrigley Jr. Company | Composition of anti-cavity chewing gum and method of fighting tooth decay by using erythrose as anticaries agent |
US5294433A (en) * | 1992-04-15 | 1994-03-15 | The Procter & Gamble Company | Use of H-2 antagonists for treatment of gingivitis |
US5286502A (en) | 1992-04-21 | 1994-02-15 | Wm. Wrigley Jr. Company | Use of edible film to prolong chewing gum shelf life |
US5229137A (en) | 1992-05-06 | 1993-07-20 | Brigham And Women's Hospital, Inc. | Methods and pharmaceutical compositions for treating episodic heartburn |
GB9221414D0 (en) * | 1992-10-13 | 1992-11-25 | Glaxo Group Ltd | Pharmaceutical compositions |
US5380530A (en) * | 1992-12-29 | 1995-01-10 | Whitehill Oral Technologies | Oral care composition coated gum |
US5496541C1 (en) * | 1993-01-19 | 2001-06-26 | Squigle Inc | Tasteful toothpaste and other dental products |
US5378131A (en) * | 1993-02-18 | 1995-01-03 | The Wm. Wrigley Jr. Company | Chewing gum with dental health benefits employing calcium glycerophosphate |
US5324530A (en) * | 1993-05-24 | 1994-06-28 | Nabisco, Inc. | Apparatus and method for making extruded chewing gum |
US5340566A (en) | 1993-08-09 | 1994-08-23 | Colgate-Palmolive Company | Method for preventing the progression of gingivitis |
US5397580A (en) | 1993-10-22 | 1995-03-14 | Wm. Wrigley Jr. Company | Continuous gum base manufacture using sequential mixers |
US5543160A (en) | 1994-09-13 | 1996-08-06 | Wm. Wrigley Jr. Company | Total chewing gum manufacture using high efficiency continuous mixing |
US5419919A (en) | 1993-10-22 | 1995-05-30 | Wm. Wrigley Jr. Company | Continuous gum base manufacture using paddle mixing |
US5494685A (en) * | 1994-05-17 | 1996-02-27 | Wm. Wrigley Jr. Company | Chewing gum with a rolling compound containing erythritol |
US5916606A (en) | 1993-09-30 | 1999-06-29 | Wm. Wrigley Jr. Company | Chewing gum compositions containing erythritol and a moisture binding agent |
US5846952A (en) | 1993-12-01 | 1998-12-08 | Marine Polymer Technologies, Inc. | Methods and compositions for poly-β-1-4-N-acetylglucosamine drug delivery |
US5580590A (en) | 1993-12-27 | 1996-12-03 | The Wm. Wrigley Jr. Company | Environmentally friendly chewing gum compositions containing elastic protein-based polymers and method of making it |
JPH07184548A (en) * | 1993-12-28 | 1995-07-25 | Meiji Seito Kk | Component for oral cavity |
JP3393560B2 (en) | 1993-12-29 | 2003-04-07 | 日本水産株式会社 | Calcium absorption promoting composition containing water-soluble chitosan and additive for promoting calcium absorption |
WO1996037182A1 (en) | 1995-05-26 | 1996-11-28 | Tom Kalili | Chewing gum with fluoride and citric acid |
US5585110A (en) | 1994-03-28 | 1996-12-17 | Kalili; Tom | Chewing gum composition with fluoride and citric acid |
US5834002A (en) | 1994-05-02 | 1998-11-10 | Josman Laboratories, Inc. | Chewing gum containing colloidal bismuth subcitrate |
US5536511A (en) | 1994-05-06 | 1996-07-16 | Wm. Wrigley Jr. Company | Chewing gum pellet coated with a hard coating containing erythritol and xylitol |
DE4415999A1 (en) | 1994-05-06 | 1995-11-09 | Bolder Arzneimittel Gmbh | Gastric acid-binding chewing pastilles |
FR2719999B1 (en) | 1994-05-17 | 1996-08-02 | Georges Serge Grimberg | Pharmaceutical composition based on guar gum and a neutralizing antacid, to which can be added a series of therapeutic active ingredients. |
EP0824870A3 (en) | 1994-06-03 | 1999-03-31 | Asama Chemical Co., Ltd. | Wheat gluten fractions |
US5670163A (en) * | 1994-06-20 | 1997-09-23 | Kv Pharmaceuticals Company | Long acting GI and esophageal protectant |
KR960006319B1 (en) | 1994-06-30 | 1996-05-13 | 이승우 | Chewing gum with pilocarpine |
US5582855A (en) | 1994-07-01 | 1996-12-10 | Fuisz Technologies Ltd. | Flash flow formed solloid delivery systems |
IT1274034B (en) * | 1994-07-26 | 1997-07-14 | Applied Pharma Res | PHARMACEUTICAL COMPOSITIONS BASED ON RUBBER TO BE CHEWED AND PROCEDURE FOR THEIR PREPARATION |
US5431929A (en) | 1994-07-28 | 1995-07-11 | Wm. Wrigley Jr. Company | Chewing gum products using oligofructose |
US5554380A (en) * | 1994-08-04 | 1996-09-10 | Kv Pharmaceutical Company | Bioadhesive pharmaceutical delivery system |
US5456677A (en) | 1994-08-22 | 1995-10-10 | Spector; John E. | Method for oral spray administration of caffeine |
US5576344A (en) | 1994-08-30 | 1996-11-19 | American Home Products Corporation | Process for reducing the adverse taste and malodor associated with H2 -antagonists |
PL184778B1 (en) | 1994-09-13 | 2002-12-31 | Wrigley W M Jun Co | Method of obtaining chewing gum base |
US5498429A (en) | 1994-10-12 | 1996-03-12 | Warner-Lambert Company | Fruit juice center-filled chewing gum |
AU4016095A (en) * | 1994-11-18 | 1996-06-17 | Procter & Gamble Company, The | Oral compositions |
US5637313A (en) * | 1994-12-16 | 1997-06-10 | Watson Laboratories, Inc. | Chewable dosage forms |
US5744164A (en) * | 1994-12-16 | 1998-04-28 | Nestec S.A. | Sustained release microparticulate caffeine formulation |
US5601858A (en) * | 1994-12-29 | 1997-02-11 | Warner-Lambert Company | Non-stick chewing gum |
US5534272A (en) | 1995-01-03 | 1996-07-09 | Bernstein Brothers Marketing Corp. | Appetite suppressant chewing gum containing chromic picolinate |
IL116674A (en) * | 1995-01-09 | 2003-05-29 | Mendell Co Inc Edward | Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof |
FR2729967A1 (en) | 1995-01-30 | 1996-08-02 | Oreal | COMPOSITIONS BASED ON AN ABRASIVE SYSTEM AND A SURFACE-ACTIVE SYSTEM |
AU721276B2 (en) | 1995-04-04 | 2000-06-29 | Wound Healing Of Oklahoma | Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant |
US5569477A (en) | 1995-04-28 | 1996-10-29 | Mccready Consumer Products, Inc. | Chewing gum containing vitamins or other active materials |
US5854267A (en) | 1995-06-02 | 1998-12-29 | Merck & Co., Inc. | Method for preventing heartburn |
US5578336A (en) | 1995-06-07 | 1996-11-26 | Monte; Woodrow C. | Confection carrier for vitamins, enzymes, phytochemicals and ailmentary vegetable compositions and method of making |
US5665386A (en) | 1995-06-07 | 1997-09-09 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
US5716928A (en) * | 1995-06-07 | 1998-02-10 | Avmax, Inc. | Use of essential oils to increase bioavailability of oral pharmaceutical compounds |
US5607697A (en) * | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
US5827526A (en) | 1995-07-11 | 1998-10-27 | Abbott Laboratories | Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans |
US5645853A (en) | 1995-08-08 | 1997-07-08 | Enamelon Inc. | Chewing gum compositions and the use thereof for remineralization of lesions in teeth |
DE19529862A1 (en) * | 1995-08-14 | 1997-02-20 | Rhone Poulenc Rorer Gmbh | Pharmaceutical preparation for oral use |
US5618517A (en) * | 1995-10-03 | 1997-04-08 | Church & Dwight Co., Inc. | Chewing gum product with dental care benefits |
US5702687A (en) | 1995-10-03 | 1997-12-30 | Church & Dwight Co., Inc. | Chewing gum product with plaque-inhibiting benefits |
US5693334A (en) | 1995-10-05 | 1997-12-02 | Church & Dwight Co., Inc. | Chewing gum product with dental health benefits |
EP0784933A3 (en) | 1995-10-16 | 1997-11-26 | Leaf, Inc. | Extended release of additives in comestible products |
US5830883A (en) | 1995-11-06 | 1998-11-03 | Duquesne University Of The Holy Ghost | Methods of creating a unique chitosan and employing the same to form complexes with drugs, delivery of the same within a patient and a related dosage form |
EP0867191A4 (en) | 1995-11-27 | 2000-01-05 | Yamanouchi Pharma Co Ltd | Drug composition |
US5629035A (en) | 1995-12-18 | 1997-05-13 | Church & Dwight Co., Inc. | Chewing gum product with encapsulated bicarbonate and flavorant ingredients |
US6066342A (en) | 1995-12-22 | 2000-05-23 | Tamer International, Ltd. | Antacid composition |
US5889028A (en) * | 1996-02-09 | 1999-03-30 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
US5736175A (en) | 1996-02-28 | 1998-04-07 | Nabisco Technology Co. | Chewing gums containing plaque disrupting ingredients and method for preparing it |
US5912007A (en) | 1996-02-29 | 1999-06-15 | Warner-Lambert Company | Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same |
US5846557A (en) | 1996-03-20 | 1998-12-08 | Cumberland Packing Corporation | Chewing gum containing cough suppressing agent |
US5866179A (en) | 1996-05-03 | 1999-02-02 | Avant-Garde Technologies & Products S.A. | Medicated chewing gum and a process for preparation thereof |
US6248378B1 (en) * | 1998-12-16 | 2001-06-19 | Universidad De Sevilla | Enhanced food products |
US5776956A (en) * | 1996-07-30 | 1998-07-07 | Lectec Corporation | Use of cotinine in treating psychiatric disorders |
US6139872A (en) * | 1996-08-14 | 2000-10-31 | Henkel Corporation | Method of producing a vitamin product |
US5877173A (en) * | 1996-08-28 | 1999-03-02 | Washington University | Preventing neuronal degeneration in Alzheimer's disease |
US5885630A (en) | 1996-09-20 | 1999-03-23 | Wm. Wrigley Jr. Company | Multiflavor gum packaging system using a volatile-flavor adsorber |
US5989588A (en) | 1996-10-04 | 1999-11-23 | Merck & Co., Inc. | Methods and compositions for preventing and treating heartburn |
US5882702A (en) * | 1996-10-07 | 1999-03-16 | Warner-Lambert Company | Process for the formation of plasticized proteinaceous materials and compositions containing the same |
WO1998018339A1 (en) | 1996-10-31 | 1998-05-07 | Hideki Aoki | Chewing gum composition and process for the production thereof |
US5897891A (en) * | 1996-11-18 | 1999-04-27 | Godfrey; John C. | Flavorful zinc compositions for oral use incorporating copper |
US6949264B1 (en) * | 1996-11-27 | 2005-09-27 | Wm. Wrigley Jr. Company | Nutraceuticals or nutritional supplements and method of making |
US6165516A (en) | 1996-11-27 | 2000-12-26 | Wm. Wrigley Jr. Company | Method of controlling release of caffeine in chewing gum |
WO1998023165A1 (en) * | 1996-11-27 | 1998-06-04 | Wm. Wrigley Jr. Company | Method of controlling release of caffeine in chewing gum and gum produced thereby |
US5980955A (en) | 1996-12-30 | 1999-11-09 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
US5798101A (en) | 1997-01-22 | 1998-08-25 | Hpf, L.L.C. | Herbal appetite suppressant and weight loss composition |
US5753255A (en) | 1997-02-11 | 1998-05-19 | Chavkin; Leonard | Chewable molded tablet containing medicinally active substances |
US5958472A (en) | 1997-02-26 | 1999-09-28 | Warner-Lambert Company | Crunchy chewing gum and process for making |
US5910308A (en) | 1997-03-19 | 1999-06-08 | Sante International Inc. | Herbal extract composition containing gynostemma pentaphyllum, crataegus pinnatifida and camellia sinensis |
GB9707977D0 (en) * | 1997-04-21 | 1997-06-11 | Procter & Gamble | Centre filled confectionery |
US5824291A (en) | 1997-06-30 | 1998-10-20 | Media Group | Chewing gum containing a teeth whitening agent |
US5958380A (en) | 1997-07-07 | 1999-09-28 | Enamelon, Inc. | Chewing gum products and the use thereof for remineralizing subsurface dental lesions and for mineralizing exposed dentinal tubules |
US6224872B1 (en) | 1997-07-31 | 2001-05-01 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Composition |
US5858383A (en) * | 1997-08-11 | 1999-01-12 | Summers Laboratories, Inc. | Methods and compositions for topical treatment of ectoparasites |
US6242019B1 (en) * | 1997-08-14 | 2001-06-05 | Warner-Lambert Company | Taste modified hard confectionery compositions containing functional ingredients |
US5900230A (en) | 1997-08-18 | 1999-05-04 | Squigle, Inc. | Dental products to treat and prevent periodontal disease |
US5922346A (en) | 1997-12-01 | 1999-07-13 | Thione International, Inc. | Antioxidant preparation |
TR200001631T2 (en) | 1997-12-08 | 2000-11-21 | Natural Medico Tech A/S | Compositions to reduce weight. |
US5928664A (en) | 1998-02-11 | 1999-07-27 | Fuisz Technologies Ltd. | Consumable gummy delivery system |
EP1495681A3 (en) | 1998-03-04 | 2005-05-25 | Dandy A/S | A coated chewing gum, a method for preparation thereof and the use of one or more active substances in the coating |
JPH11266872A (en) * | 1998-03-20 | 1999-10-05 | Suntory Ltd | Screening of substance suppressing activation of nf-kappa b |
US6200604B1 (en) * | 1998-03-27 | 2001-03-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US6024988A (en) * | 1998-06-01 | 2000-02-15 | Wm. Wrigley Jr. Company | Caffeine chewing gum |
WO2000006127A1 (en) | 1998-07-30 | 2000-02-10 | Warner-Lambert Company | Centerfill delivery system for nutraceuticals |
US7163705B2 (en) * | 1998-12-15 | 2007-01-16 | Wm. Wrigley Jr. Company | Coated chewing gum product and method of making |
US6586023B1 (en) * | 1998-12-15 | 2003-07-01 | Wm. Wrigley Jr. Company | Process for controlling release of active agents from a chewing gum coating and product thereof |
US6627234B1 (en) | 1998-12-15 | 2003-09-30 | Wm. Wrigley Jr. Company | Method of producing active agent coated chewing gum products |
US6773716B2 (en) * | 1999-04-06 | 2004-08-10 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations |
US20020159956A1 (en) | 1999-04-06 | 2002-10-31 | Ream Ronald L. | Over-coated chewing gum formulations |
US20020110581A1 (en) * | 1999-04-06 | 2002-08-15 | Ream Ronald L. | Over-coated product including consumable center and medicament |
US6322806B1 (en) | 1999-04-06 | 2001-11-27 | Wm. Wrigley Jr. Company | Over-coated chewing gum formulations including tableted center |
AU3885201A (en) | 1999-09-20 | 2001-04-24 | Mastercare | Diet and weight control gum and sucker |
US6350480B1 (en) | 1999-12-30 | 2002-02-26 | Wm. Wrigley Jr. Company | Chewing gum product including a hydrophilic gum base and method of producing |
GB0006555D0 (en) | 2000-03-17 | 2000-05-10 | Nestle Sa | Edible chewing gum |
US20050002992A1 (en) | 2003-06-17 | 2005-01-06 | Mccleary Edward Larry | Foods, beverages, condiments, spices and salad dressings with specialized supplements |
US20020127189A1 (en) | 2001-03-12 | 2002-09-12 | Myers Thomas R. | Chewing gum containing synephrine, ephedrine and caffeine |
US7244455B2 (en) * | 2002-01-16 | 2007-07-17 | Warner-Lambert Company | Center-filled chewing gum containing a deliverable form of calcium |
US20040151771A1 (en) | 2003-02-04 | 2004-08-05 | Gin Jerry B. | Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth |
-
2000
- 2000-09-19 AU AU38852/01A patent/AU3885201A/en not_active Abandoned
- 2000-09-19 WO PCT/US2000/025608 patent/WO2001021147A1/en active Application Filing
- 2000-09-19 US US09/664,630 patent/US6491540B1/en not_active Expired - Fee Related
-
2002
- 2002-12-10 US US10/316,700 patent/US6652839B2/en not_active Expired - Fee Related
-
2003
- 2003-08-21 US US10/646,503 patent/US6869614B2/en not_active Expired - Fee Related
-
2005
- 2005-03-17 US US11/084,707 patent/US7351425B2/en not_active Expired - Fee Related
-
2008
- 2008-03-20 US US12/052,054 patent/US8679522B2/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5409905A (en) * | 1981-01-05 | 1995-04-25 | Eby, Iii; George A. | Cure for commond cold |
US4980178A (en) * | 1986-12-10 | 1990-12-25 | Warner-Lambert Company | Reduced calorie center-filled chewing gum compositions having improved stability |
US5891422A (en) * | 1996-10-10 | 1999-04-06 | Warner-Lambert Company | Antimicrobial composition containing a C3 -C6 alcohol |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2625965C2 (en) * | 2011-12-16 | 2017-07-20 | Вм. Ригли Дж. Компани | Chewing gum and method for its manufacturing |
Also Published As
Publication number | Publication date |
---|---|
US6869614B2 (en) | 2005-03-22 |
AU3885201A (en) | 2001-04-24 |
US7351425B2 (en) | 2008-04-01 |
US20080317902A1 (en) | 2008-12-25 |
US6491540B1 (en) | 2002-12-10 |
US20060024354A1 (en) | 2006-02-02 |
US20040037788A1 (en) | 2004-02-26 |
US8679522B2 (en) | 2014-03-25 |
US6652839B2 (en) | 2003-11-25 |
US20030103910A1 (en) | 2003-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6491540B1 (en) | Center-filled supplement gum | |
US9387168B2 (en) | Chewing gum with tomatidine | |
EP1073346B1 (en) | Healthbar formulations | |
US20020187204A1 (en) | Diet composition and method of weight management | |
US20020192316A1 (en) | Novel chocolate composition as delivery system for nutrients and medications | |
JP2958663B2 (en) | Nicotine-containing stimulant unit | |
US20130236595A1 (en) | Food product providing sustained blood levels of exogenous substances | |
CN102461713A (en) | Sugar-free chewing gum with hypoglycemic function and preparation method thereof | |
US20200069581A1 (en) | Cannabinoid and anesthetic gum and lozenge compositions and methods | |
WO2007042745A1 (en) | Chocolate based appetite suppressant | |
US20070014834A1 (en) | Apparatus and methods of improved delivery of orally-administered therapeutic substances | |
US20100055251A1 (en) | Fat soluble food bar | |
US9253991B2 (en) | Chewing gum with B vitamins | |
US20200069638A1 (en) | Cannabinoid and menthol gum and lozenge compositions and methods | |
US20130004604A1 (en) | Dark chocolate delivery system for a combination of dietary supplements and pharmaceuticals | |
US20070218030A1 (en) | Dietetic Preparation for Prevention and Treatment of Osteoporosis | |
US6153629A (en) | Use of a combination of an anti-smoking composition and a dietary composition in smoking cessation | |
KR102269586B1 (en) | Diet candy for control of appetite and weight loss | |
US20050112149A1 (en) | Single-dose taste inhibitor units | |
KR20180056199A (en) | Manufacturing method of gum for diet containing Moringa Oleifera extract | |
CN111529642A (en) | Traditional Chinese medicine stick cream for children and preparation method thereof | |
US20140242202A1 (en) | Composition for Reducing Side- and After-Effects of Cancer Treatment | |
RU2811131C1 (en) | Jelly candy | |
US11376227B2 (en) | Cannabinoid and menthol gum and lozenge compositions and methods | |
WO2021177942A1 (en) | Cannabinoid and menthol gum and lozenge compositions and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |